BLUE

bluebird bio Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

BLUE price

bluebird bio

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BLUE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BLUE

Valuation

P/E

0.00

Sector -3.50

Industry -3.50

P/BV

0.00

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

10.25

Sector -214.99

Industry -214.99

EV/EBIT

3.39

Sector -47.59

Industry -47.59

P/EBITDA

Sector -21.41

Industry -21.41

P/EBIT

Sector -28.65

Industry -28.65

P/Total Assets

Sector 1.19

Industry 1.19

P/Net Current Assets

0.00

Sector -11.97

Industry -11.97

P/Working Capital

0.00

Sector -167.95

Industry -167.95

EPS

-20.00

Sector -1.81

Industry -1.81

BVPS

-5.79

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

27.12%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-19.84%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-60.01%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.13

Sector 0.02

Industry 0.02

Profitability

ROE

345.57%

Sector -56.04%

Industry -56.04%

ROA

-67.57%

Sector -60.31%

Industry -60.31%

ROIC

-21.35%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.55

Sector 2.89

Industry 2.89

Net Debt / EBITDA

10.25

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

3.39

Sector -8.06

Industry -8.06

Net Debt / Equity

1.36

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

-0.20

Sector 0.46

Industry 0.46

Liabilities/Assets

1.20

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

12.63%

Sector -

Industry -

5Y Earnings CAGR

-24.58%

Sector -

Industry -

Fundamentals BLUE

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BLUE bluebird bio Inc.	$0.00	-	0.00%	0.00	0.00	345.57%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BLUE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT bluebird bio

bluebird bio Inc.

Average Investor10 user rating

4.0 (1 people)

United States

34 years

Founded: 1992

2013

Time since IPO - 13 years

1.090

Employees

bluebird bio Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-57.87 million.

The company employs approximately 1.090 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, bluebird bio Inc. reported $103.94 million in revenue, generating net income of $-199.98 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BLUE.

Market cap

Net worth

$-57.87 million

$-57,870,000.00

Assets

$295.96 million

$295,960,000.00

Total Shares Outstanding

10.00 million

10,000,000

Average Daily Trading Volume

$636.02 Thousand

$636,022.76

Sector

Health Care

Industry

Biotechnology

BLUE

BLUE revenue and profits

Financial Results BLUE

DRAG THE FRAME TO SEE MORE DATA

BLUE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of bluebird bio (BLUE) today?

A cotação de bluebird bio (BLUE) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de bluebird bio (BLUE) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de bluebird bio (BLUE) e dados de ações do Ibovespa e mercados internacionais.

Quando bluebird bio (BLUE) paga dividendos?

bluebird bio (BLUE) não distribuiu dividendos no último ano.

Is bluebird bio (BLUE) a good investment?

Atualmente, bluebird bio (BLUE) está cotada a US$ 0.00, com um P/L de 0.00, representando um desvio de -606% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy bluebird bio (BLUE) stock?

Investir em ações de bluebird bio (BLUE) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of bluebird bio (BLUE) yield today?

A rentabilidade de bluebird bio (BLUE) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de bluebird bio (BLUE) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BLUE

bluebird bio Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BLUE

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING BLUE WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT bluebird bio

bluebird bio Inc.

United States

34 years

2013

1.090

PROFIT X PRICE BLUE

Financial Results BLUE

BLUE cash flow

Asset, Revenue and Profit Growth - BLUE

BLUE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions